Hans-Juergen Mair

This inventor holds 9 USPTO granted patents and 3 published patent applications, plus 3 CIPO patents and 4 EPO patents. Top assignees: Hoffmann-La Roche Inc., Plexxikon Inc.. Active years: 2002-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hans-Juergen Mair. Retrieved from https://idiyas.com/inventor/hans-juergen-mair

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9 (Patent Applications = 3)

% Patents Active = 88.9

CIPO Patents = 3

EPO Patents = 4 (Patent Applications = 5)

Average Co-Inventor Count = 3.9

ph-index = 5

Forward Citations = 103(Granted Patents)

Company Filing History:

9 out of 5,026

Hoffmann-La Roche Inc.

where one patent can have more than one assignee

Years Active: 2002-2017

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9663517 - Compositions and uses thereof (2017-05-30),

2. 9603816 - Process (2017-03-28),

3. 9447089 - Compositions and uses thereof (2016-09-20),

4. 8741920 - Process for the manufacture of pharmaceutically active compounds (2014-06-03),

5. 8664403 - Process (2014-03-04),

6. 8530661 - Process for the manufacture of pharmaceutically active compounds (2013-09-10),

7. 8329724 - Process for the manufacture of pharmaceutically active compounds (2012-12-11),

8. 7872141 - Processes for the manufacture of a pyrrolidine-3,4-dicarboxamide derivative (2011-01-18),

9. 6462226 - Process for the preparation of 4,5-diamino shikimic acid derivatives (2002-10-08),

Title: Inventor Spotlight: Hans-Juergen Mair

Introduction

Hans-Juergen Mair is a notable inventor based in Loerrach, Germany. With a remarkable track record of 9 patents to his name, he has significantly contributed to the field of innovation, particularly in pharmaceutical compositions.

Latest Patents

Among his latest inventions, Mair has developed compositions involving solid dispersions, solid molecular complexes, salts, and crystalline polymorphs related to propane-1-sulfonic acid. His most recent patent details a process for preparing S-[2-[1-(2-ethylbutyl)cyclohexylcarbonylamino]-phenyl] 2-methylthiopropionate, a compound with potential as a pharmaceutically active agent.

Career Highlights

Throughout his esteemed career, Hans-Juergen Mair has worked for prominent companies such as Hoffmann-La Roche Inc. and Plexxikon Inc. His contributions in these organizations have enabled advancements in pharmaceutical research and development.

Collaborations

Mair has collaborated with several talented professionals in the field. Notable coworkers include Stefan Hildbrand and Roumen Nikolaev Radinov, who have played essential roles in his inventive projects.

Conclusion

Hans-Juergen Mair continues to pave the way for innovations in pharmaceuticals through his inventive expertise and collaborative spirit. His patent portfolio is a testament to his dedication and impact on the industry.

Profile summary based on public USPTO records.